Norris Comprehensive Cancer Center — Los Angeles, California

Public research footprint of Norris Comprehensive Cancer Center, compiled from the ClinicalTrials.gov public registry.

1,323

Registered studies

411

Active

190

Recruiting now

595

Completed

278

Stopped or withdrawn

Most-studied conditions

Stage II Bladder Urothelial Carcinoma AJCC v6 and v7 · Recurrent Skin Squamous Cell Carcinoma With Sarcomatoid… · B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 · Stage IB Lung Non-Small Cell Carcinoma AJCC v7

Recently updated registry entries

NCT07293247 — A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With… (Recruiting)
NCT05432804 — Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy… (Recruiting)
NCT06065748 — A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Norris Comprehensive Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.